Drug intelligence / Profile preview

KLX-01

Development stage
Unknown
Lead developer
KetoLipix Therapeutics
Modality
Small Molecules
Administration
Oral
01

Overview

KLX-01 is an investigational small molecule ketone ester developed by KetoLipix Therapeutics. It is designed as an active pharmaceutical ingredient (API) to induce exogenous metabolic ketosis, providing a rapid and controlled elevation of blood ketone levels, specifically beta-hydroxybutyrate (BHB). By serving as an alternative energy substrate to glucose, KLX-01 aims to address metabolic deficiencies in various tissues. The therapeutic focus of KetoLipix includes conditions such as heart failure and neurodegenerative disorders, where enhancing cellular energetics through ketosis may provide clinical benefit. Unlike dietary ketone supplements, KLX-01 is being developed under pharmaceutical standards for specific medical indications.

Other names
ketone ester
02

Targets

MCT4 (Monocarboxylate transporter 4)HCAR2 (Hydroxycarboxylic acid receptor 2)

Beyond the preview

Go deeper on KLX-01.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KLX-01.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call